Septerna, Inc. Common Stock (SEPN)

Septerna, Inc. Common Stock (SEPN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.8B; returns 1 day -1.1%, 1 week +11.2%, 1 year +85.5%.

Septerna, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of novel oral small molecule drugs targeting G protein-coupled receptors (GPCRs). The company's proprietary Native Complex Platform™ enables it to pursue historically difficult-to-drug GPCR targets.

Groups SEPN belongs to

• GPCR Targeting
• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Drug Discovery
• Endocrinology
• Strategic Partnerships
• Metabolic Disorders
• Life Sciences

SEPN financial model: income statement, cash flow and balance sheet